|
|
|
NASDAQ Gets Genaissance IPO
|
Business New Haven
9/4/2000
By: BNH
|
NEW HAVEN - Science Park's Genaissance Pharmaceuticals (NASDAQ: GNSC), which develops technologies for “smarter” clinical trials and for approving sales of approved drugs, announced an initial public offering (IPO) of six million shares of common stock on the NASDAQ exchange on August 2. The offering price was $13 per share; the stock was trading in the same range in mid August.
The company correlates drug responses with the inherited differences in patients, a spokesperson explains. It
does this using a combination of informatics, propietary genomic markers
and a procedure for analyzing clinical
samples.
|
Go FirstGo PreviousGo
NextGo LastGo
to Index
|
|
